TRXADE HEALTH INC (MEDS) Stock Balance Sheet
NASDAQ:MEDS • US89846A4058
Current stock price
7.59 USD
+0.35 (+4.83%)
At close:
7.591 USD
+0 (+0.01%)
After Hours:
| MRQ (2024-6-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 7.72M | 151.91K | 1.13M | 3.12M | 5.92M | |||
| Receivables | 3.54M | 2.49M | 730.00K | 980.00K | 1.89M | |||
| Inventories | 6.44K | 970.00 | 120.00K | 60.00K | 1.26M | |||
| Other Current Assets | 874.12K | 107.77K | 110.00K | 220.00K | 150.00K | |||
| Total Current Assets | 12.14M | 2.75M | 2.09M | 4.37M | 9.22M | |||
| Non-Current Assets | ||||||||
| PPE Net | 182.05K | 806.63K | 1.12M | 1.33M | 550.00K | |||
| Investments And Advances | 2.50M | N/A | N/A | N/A | N/A | |||
| Goodwill | N/A | N/A | N/A | N/A | 0.00 | |||
| Intangibles | 0.00 | 8.96M | 450.00K | N/A | N/A | |||
| Other Non-Current Assets | 22.04K | 10.53K | 50.00K | 60.00K | 20.00K | |||
| Total Non-Current Assets | 2.70M | 9.78M | 1.62M | 1.40M | 570.00K | |||
| TOTAL ASSETS | 14.85M | 12.53M | 3.71M | 5.77M | 9.79M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | 6.53M | 170.00K | 0.00 | 230.00K | |||
| Accrued Expenses | 533.06K | 540.69K | 490.00K | 450.00K | 350.00K | |||
| Accounts Payable | 726.27K | 2.08M | 730.00K | 480.00K | 260.00K | |||
| Other Current Liabilities | 1.64M | 2.40M | 760.00K | 0.00 | 10.00K | |||
| Total Current Liabilities | 2.90M | 11.56M | 2.15M | 930.00K | 840.00K | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 25.00K | 330.00K | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 161.00K | 409.21K | 890.00K | 1.07M | 270.00K | |||
| Total Non-Current Liabilities | 161.00K | 434.20K | 800.00K | 1.07M | 270.00K | |||
| TOTAL LIABILITIES | 3.06M | 11.99M | 2.95M | 2.00M | 1.11M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -26.50M | -33.25M | -19.72M | -16.25M | -10.93M | |||
| Additional Paid In Capital | 38.29M | 33.79M | 20.48M | 20.02M | 19.61M | |||
| Minority Interest | N/A | 0.00 | -420.00K | N/A | N/A | |||
| Common Shares | 10.00 | 10.00 | 0.00 | 0.00 | 0.00 | |||
| Shares Outstanding | 1.41M | 905.01K | 630.00K | 540.00K | 540.00K | |||
| Tangible Book Value per Share | 8.38 | -9.30 | 0.49 | 6.98 | 16.07 | |||
| Total Shareholders' Equity | 11.79M | 542.35K | 760.00K | 3.77M | 8.68M | |||
| TOTAL LIABILITIES AND EQUITY | 14.85M | 12.53M | 3.71M | 5.77M | 9.79M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | 0.05 | 0.43 | N/A | N/A | |||
| Current Ratio | 4.18 | 0.24 | 0.97 | 4.70 | 10.98 | |||
| Return On Assets (ROA) | 28.09% | -142.37% | -93.53% | -92.20% | -25.94% | |||
| Return On Equity (ROE) | 35.39% | -3290.05% | -456.58% | -141.11% | -29.26% | |||
| Return On Invested Capital (ROIC) | N/A | N/A | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | N/A | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexgc) | N/A | N/A | N/A | N/A | N/A | |||
All data in USD , ROIC based on taxRate of 0.21